Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |